Akèy › Anplwayè › SAI-Med Partners LLC
SAI-Med Partners LLC: Salè H-1B ak pajon
SAI-Med Partners LLC depoze 16 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 16. Medyèn salè yo ofri a: $110,000.
Èske SAI-Med Partners LLC pajone visa H-1B?
SAI-Med Partners LLC depoze 16 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Jun 11, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Life Sciences Markets Consultant/Project Manager | 5 | $100,000 |
| Life Sciences Markets Consultant | 3 | $85,000 |
| Assoc Director - Specialty Therapeutics and Related (STAR) | 1 | $110,000 |
| Senior Director, Oncology Practice | 1 | $145,000 |
| Director - Specialty Therapeutics and Related (STAR) | 1 | $130,000 |
| TheraTraQ Pharma/Healthcare Services Division Head | 1 | $200,000 |
| Associate Director, Immunology Practice | 1 | — |
| Vice President, Oncology Practice | 1 | $185,000 |
| Exec Director - Specialty Therapeutics and Related (STAR) | 1 | $145,000 |
| Associate Director - Generics, Biosimilars and Mature Brands | 1 | $120,000 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 6 | $97,500 |
| FY2024 | 3 | $150,000 |
| FY2025 | 3 | $100,000 |
| FY2026 | 4 | $132,500 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Associate Director - Generics, Biosimilars and Mature Brands | $120,000–$150,000 Nivo IV | Reading, PA | Jun 11, 2026 | Jun 22, 2026 | Certifye |
| Life Sciences Markets Consultant | $85,000–$115,000 Nivo II | Reading, PA | Jun 1, 2026 | Jun 8, 2026 | Certifye |
| Exec Director - Specialty Therapeutics and Related (STAR) | $145,000–$230,000 Nivo II | Reading, PA | Apr 9, 2026 | May 15, 2026 | Certifye |
| Vice President, Oncology Practice | $185,000–$260,000 Nivo III | Reading, PA | Apr 7, 2026 | May 4, 2026 | Certifye |
| Life Sciences Markets Consultant/Project Manager | $88,000–$138,000 Nivo III | Reading, PA | Jun 17, 2025 | Jun 24, 2025 | Certifye |
| Life Sciences Markets Consultant/Project Manager | $115,000–$150,000 Nivo III | Reading, PA | Mar 25, 2025 | Apr 7, 2025 | Certifye |
| Life Sciences Markets Consultant/Project Manager | $100,000–$140,000 Nivo III | Reading, PA | Dec 19, 2024 | May 1, 2025 | Certifye |
| Associate Director, Immunology Practice | $135,200–$156,000 tan pasyèl · Nivo II | Reading, PA | Jun 18, 2024 | Jul 1, 2024 | Certifye |
| Life Sciences Markets Consultant/Project Manager | $100,000–$135,000 Nivo III | Reading, PA | Mar 12, 2024 | Apr 1, 2024 | Certifye |
| TheraTraQ Pharma/Healthcare Services Division Head | $200,000–$400,000 Nivo IV | Reading, PA | Mar 4, 2024 | May 1, 2024 | Certifye |
| Life Sciences Markets Consultant/Project Manager | $80,000–$120,000 Nivo III | Reading, PA | Sep 13, 2023 | Oct 3, 2023 | Certifye |
| Senior Director, Oncology Practice | $145,000–$215,000 Nivo III | Reading, PA | Aug 8, 2023 | Aug 18, 2023 | Certifye |
| Director - Specialty Therapeutics and Related (STAR) | $130,000–$170,000 Nivo I | Reading, PA | Jul 17, 2023 | Aug 1, 2023 | Certifye |
| Assoc Director - Specialty Therapeutics and Related (STAR) | $110,000–$160,000 Nivo IV | Reading, PA | Jun 12, 2023 | Jul 1, 2023 | Certifye |
| Life Sciences Markets Consultant | $85,000–$110,000 Nivo II | Los Angeles, CA | Jun 12, 2023 | Jun 24, 2023 | Certifye |
| Life Sciences Markets Consultant | $85,000–$110,000 Nivo II | Reading, PA | Apr 11, 2023 | Apr 24, 2023 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).